openPR Logo
Press release

Uterine Fibroid Market Trend, Segmentation And Industry Analysis Research Report 2018

01-22-2018 07:09 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

/ PR Agency: Market Research Future
Uterine Fibroid Market

Uterine Fibroid Market

The Market Research Future provides detailed analysis of “Global Uterine Fibroid Market Research Report – forecast till 2022” by type, by indication and by end user.
The Worldwide Uterine Fibroid market Research Report provides detailed analysis of the key regional market status of the Healthcare Industry. The Uterine Fibroids Market is expected to reach USD 39,993.2 Million by the end of the forecasted period and is expected to grow at a CAGR of 3.24%.
Uterine Fibroids are the abnormal growth that gets developed inside or on the wall of a woman’s uterus. These are also known as leiomyoma or myomas. These are noncancerous growths that cause symptoms such as heavy bleeding between or during the menstrual cycle, pain in pelvis or lower back, increased menstrual cramping, swelling enlargement of the abdomen. Increasing prevalence due to heredity and rising number of treatments to cure this disease has fuelled the growth of this market.
Key Players for U.S. Uterine Fibroid Market:
Some of the key players in this market are: AstraZeneca (England), Cook Medical Inc. (US), Boston Scientific Corporation (US), GE Healthcare (U.K.), AbbVie Inc. (U.S.), Hologic (U.S.), and others.
Key Finding
• The U.S. Uterine Fibroid Market and is expected to reach USD 39,993.2 million by 2022.
• By Type, Intramural Fibroids holds the largest market share of U.S. Uterine Fibroid Market and is expected to reach USD 14,972.5 million by 2022.
• By Treatment, hysterectomy holds the largest market share of U.S. Uterine Fibroid Market and is expected to reach USD 8,042.3 million by 2022.
Get Sample copy @ https://www.marketresearchfuture.com/sample_request/2394 .
Uterine Fibroid Market Segments:
U.S. Uterine Fibroid Market has been segmented on the basis of type which comprises of Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others. On the basis of diagnosis the market is segmented into Medical Resonance Imaging (MRI) scanners, Computed tomography (CT), Ultrasounds and others. On the basis of treatment the market is segmented into Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy.
Study Objectives U.S. Uterine Fibroid Market:
provide detailed analysis of the market structure along with forecast for the next 5 years of the various segments and sub-segments of the U.S. Uterine Fibroid Market, provide insights about factors affecting the market growth, analyse the market based on various factors - price analysis, supply chain analysis, porters five force analysis etc.
To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa, provide country level analysis of the market with respect to the current market size, volume, average selling price and future prospective, provide overview of key players and their strategic profiling in the market, comprehensively analysing their core competencies, and drawing a competitive landscape for the market, track and analyse competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments U.S.
Regional Analysis of U.S. Uterine Fibroid Market:
The U.S. market for uterine fibroids is growing steadily. The market for uterine fibroids is growing with the CAGR of 3.24% during the forecast period from 2016-2022. California, Texas, Florida, New York are some of the states which are estimated to have highest prevalence of uterine fibroids.
Get Discount @ https://www.marketresearchfuture.com/check-discount/2394 .
TABLE OF CONTENTS
1 INTRODUCTION
1.1.1 Prevalence Of The Uterine Fibroids In U.S. 8
2 SCOPE OF STUDY
2.1 Research Objective 10
2.2 Assumptions & Limitations 10
2.2.1 Assumptions 10
2.2.2 Limitations 10
2.3 Market Structure 11
3 RESEARCH METHODOLOGY
3.1 Primary Research 13
3.2 Secondary Research 13
4 U.S. UTERINE FIBROID MARKET
4.1 Introduction 15
4.2 U.S. Uterine Fibroid Market, By Type 17
4.3 U.S. Uterine Fibroid Market, By Diagnosis 19
4.4 U.S. Uterine Fibroid Market, By Treatment 21
…Continued
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

MRFR has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Our Research Analysts are eager to share their knowledge and assist you in refining market research parameters, choosing right market studies, and evaluating both the market scope and the research methodologies of varied segments.

We bridge the gap between our clients and their clients by identifying and decoding just the target group, while generating leads with the highest accuracy.

Years of research into diverse fields of work has ingrained within us, a proficiency so distinguished that our industry-specific specialists identify with your business ideas and feel the pulse of your challenges and opportunities. This enables us for providing assistance, through our consulting and strategic consulting services, in informed managerial decision making. In order to stay updated with technology and work process of the industries, WantStats Research and Media often conducts industrial visits for its research analysts. Relevant inputs from various established market participants, help our clients make significant contribution in respective markets are a huge motivation for all of us to endlessly furnish quality. We depend greatly on profound insights into complex realms of our study.

Pune, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Uterine Fibroid Market Trend, Segmentation And Industry Analysis Research Report 2018 here

News-ID: 911880 • Views:

More Releases from Market Research Future

Glue Machine Market to Reach USD 14.9 Billion by 2035, Growing at 4.56% CAGR
Glue Machine Market to Reach USD 14.9 Billion by 2035, Growing at 4.56% CAGR
The Glue Machine Market is witnessing significant growth due to the increasing adoption of adhesive technologies across various industries, including packaging, woodworking, automotive, furniture, and construction. Valued at USD 9.15 billion in 2024, the market is projected to reach USD 14.9 billion by 2035, registering a CAGR of 4.56% between 2025 and 2035. Glue machines, also known as adhesive application machines, are critical for efficiently dispensing adhesives in industrial and commercial
Expansion Valves Market to Reach USD 5.39 Billion by 2035, Growing at 4.62% CAGR
Expansion Valves Market to Reach USD 5.39 Billion by 2035, Growing at 4.62% CAGR
The expansion valves market is witnessing steady growth due to increasing demand for efficient heating, ventilation, air conditioning, and refrigeration (HVACR) systems across residential, commercial, and industrial sectors. Valued at USD 3.28 billion in 2024, the market is projected to reach USD 5.39 billion by 2035, growing at a CAGR of 4.62% between 2025 and 2035. Expansion valves, also known as thermostatic expansion valves (TXVs) or electronic expansion valves (EEVs), are
Cheese Packaging Market to Reach USD 101.31 Billion by 2034, Growing at 3.50% CAGR
Cheese Packaging Market to Reach USD 101.31 Billion by 2034, Growing at 3.50% CA …
The Cheese Packaging Market is poised for steady growth over the next decade due to rising demand for dairy products, evolving consumer preferences, and increasing focus on food safety and sustainability. According to recent estimates, the market was valued at USD 71.87 billion in 2024 and is projected to reach USD 101.31 billion by 2034, growing at a compound annual growth rate (CAGR) of 3.50% between 2025 and 2034. Cheese packaging
Maritime Market to Reach USD 2,920 Billion by 2035, Growing at 2.69% CAGR
Maritime Market to Reach USD 2,920 Billion by 2035, Growing at 2.69% CAGR
The Maritime Market is a cornerstone of international trade, logistics, and economic connectivity, serving as the backbone of global commerce. Valued at USD 2,181.1 billion in 2024, the market is projected to expand to USD 2,920 billion by 2035, registering a steady CAGR of 2.69% between 2025 and 2035. Despite modest growth, the industry's scale and importance are unmatched, as more than 80% of global trade volume is carried by

All 5 Releases


More Releases for Fibroid

The Growing Uterine Fibroid Treatment Devices Market 2024-2032
In the realm of women's health, uterine fibroids represent a prevalent concern affecting millions globally. Uterine fibroids, also known as leiomyomas or myomas, are non-cancerous growths that develop in the muscular wall of the uterus. These growths can vary in size, number, and location within the uterus, and they can cause various symptoms such as heavy menstrual bleeding, pelvic pain or pressure, frequent urination, and reproductive issues including infertility and
Uterine Fibroid Treatment Devices Market is estimated to be US$ 15.6 billion by …
The Uterine Fibroid Treatment Devices Market is a critical sector within women's healthcare, dedicated to developing and providing advanced medical devices for the diagnosis and treatment of uterine fibroids. Uterine fibroids, or leiomyomas, are noncancerous growths that occur in the uterus and can lead to various symptoms, impacting the health and well-being of many women. This market addresses the need for innovative and minimally invasive solutions to alleviate symptoms such
Compassionate Care: Uterine Fibroid Treatment Devices
Uterine fibroids, non-cancerous growths that develop in the uterus, have become a pervasive health concern among women worldwide, especially those of childbearing age. These benign tumors can lead to a range of symptoms, such as heavy menstrual bleeding, pelvic pain, and fertility issues. With the escalating prevalence of uterine fibroids, there is a growing demand for innovative and effective treatment options. This has spurred the expansion of the Uterine Fibroid
Uterine Fibroid Treatment Market Size, Share, Development by 2025
LP INFORMATION recently released a research report on the Uterine Fibroid Treatment market analysis, which studies the Uterine Fibroid Treatment's industry coverage, current market competitive status, and market outlook and forecast by 2025. Global “Uterine Fibroid Treatment Market 2020-2025” Research Report categorizes the global Uterine Fibroid Treatment market by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players
Japan Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023
ReportsWorldwide has announced the addition of a new report title Japan Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023 to its growing collection of premium market research reports. GlobalData’s new report, "Japan Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023", provides key procedures data on the Japan Uterine Fibroid Embolization (UFE) Procedures. The report provides procedure volumes within market segments - Gastric Bypass Procedures, Gastric Banding Procedures, Sleeve Gastrectomy Procedures and
Brazil Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023
ReportsWorldwide has announced the addition of a new report title Brazil Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023 to its growing collection of premium market research reports. GlobalData’s new report, "Brazil Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023", provides key procedures data on the Brazil Uterine Fibroid Embolization (UFE) Procedures. The report provides procedure volumes within market segments - Gastric Bypass Procedures, Gastric Banding Procedures, Sleeve Gastrectomy Procedures and